Current and Former Smoking and Risk for Venous Thromboembolism: A Systematic Review and Meta-Analysis

English version České info

Background:
Smoking is a well-established risk factor for atherosclerotic disease, but its role as an independent risk factor for venous thromboembolism (VTE) remains controversial. We conducted a meta-analysis to summarize all published prospective studies and case-control studies to update the risk for VTE in smokers and determine whether a dose–response relationship exists.

Methods and Findings:
We performed a literature search using MEDLINE (source PubMed, January 1, 1966 to June 15, 2013) and EMBASE (January 1, 1980 to June 15, 2013) with no restrictions. Pooled effect estimates were obtained by using random-effects meta-analysis. Thirty-two observational studies involving 3,966,184 participants and 35,151 VTE events were identified. Compared with never smokers, the overall combined relative risks (RRs) for developing VTE were 1.17 (95% CI 1.09–1.25) for ever smokers, 1.23 (95% CI 1.14–1.33) for current smokers, and 1.10 (95% CI 1.03–1.17) for former smokers, respectively. The risk increased by 10.2% (95% CI 8.6%–11.8%) for every additional ten cigarettes per day smoked or by 6.1% (95% CI 3.8%–8.5%) for every additional ten pack-years. Analysis of 13 studies adjusted for body mass index (BMI) yielded a relatively higher RR (1.30; 95% CI 1.24–1.37) for current smokers. The population attributable fractions of VTE were 8.7% (95% CI 4.8%–12.3%) for ever smoking, 5.8% (95% CI 3.6%–8.2%) for current smoking, and 2.7% (95% CI 0.8%–4.5%) for former smoking. Smoking was associated with an absolute risk increase of 24.3 (95% CI 15.4–26.7) cases per 100,000 person-years.

Conclusions:
Cigarette smoking is associated with a slightly increased risk for VTE. BMI appears to be a confounding factor in the risk estimates. The relationship between VTE and smoking has clinical relevance with respect to individual screening, risk factor modification, and the primary and secondary prevention of VTE.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Current and Former Smoking and Risk for Venous Thromboembolism: A Systematic Review and Meta-Analysis. PLoS Med 10(9): e32767. doi:10.1371/journal.pmed.1001515
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001515

Souhrn

Zdroje

1. SchultzH (1998) Tobacco or health: A global status report. Ann Saudi Med 18: 195.

2. WHO urges more countries to require large, graphic health warnings on tobacco packaging: the WHO report on the global tobacco epidemic, 2011 examines anti-tobacco mass-media campaigns. Cent Eur J Public Health 19: 133, 151.

3. FlintermanLE, van HylckamaVA, CannegieterSC, RosendaalFR (2012) Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med 9: e1001155 doi:10.1371/journal.pmed.1001155

4. CushmanM, TsaiAW, WhiteRH, HeckbertSR, RosamondWD, et al. (2004) Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 117: 19–25.

5. LindbladB, SternbyNH, BergqvistD (1991) Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 302: 709–711.

6. TavoraF, CrowderC, KutysR, BurkeA (2008) Discrepancies in initial death certificate diagnoses in sudden unexpected out-of-hospital deaths: the role of cardiovascular autopsy. Cardiovasc Pathol 17: 178–182.

7. HolstAG, JensenG, PrescottE (2010) Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation 121: 1896–1903.

8. SeverinsenMT, KristensenSR, JohnsenSP, DethlefsenC, TjonnelandA, et al. (2009) Smoking and venous thromboembolism: a Danish follow-up study. J Thromb Haemost 7: 1297–1303.

9. RosengrenA, FredenM, HanssonPO, WilhelmsenL, WedelH, et al. (2008) Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost 6: 558–564.

10. TsaiAW, CushmanM, RosamondWD, HeckbertSR, PolakJF, et al. (2002) Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 162: 1182–1189.

11. AgenoW, BecattiniC, BrightonT, SelbyR, KamphuisenPW (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117: 93–102.

12. GreenlandS (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9: 1–30.

13. HigginsJP, ThompsonSG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539–1558.

14. LEVINML (1953) The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 9: 531–541.

15. van HouwelingenHC, ArendsLR, StijnenT (2002) Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21: 589–624.

16. GreenlandS, LongneckerMP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135: 1301–1309.

17. MillerJJ (1978) The inverse of the Freeman-Turkey double arcsine transformation. Am Stat 32: 138.

18. EggerM, DaveySG, SchneiderM, MinderC (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629–634.

19. GoldhaberSZ, GrodsteinF, StampferMJ, MansonJE, ColditzGA, et al. (1997) A prospective study of risk factors for pulmonary embolism in women. JAMA 277: 642–645.

20. HanssonPO, ErikssonH, WelinL, SvardsuddK, WilhelmsenL (1999) Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: “the study of men born in 1913”. Arch Intern Med 159: 1886–1890.

21. KlatskyAL, ArmstrongMA, PoggiJ (2000) Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 85: 1334–1337.

22. GlynnRJ, RosnerB (2005) Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 162: 975–982.

23. LindqvistPG, EpsteinE, OlssonH (2009) The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study. Br J Haematol 144: 234–240.

24. RosengrenA, FredenM, HanssonPO, WilhelmsenL, WedelH, et al. (2008) Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost 6: 558–564.

25. LutseyPL, VirnigBA, DurhamSB, SteffenLM, HirschAT, et al. (2010) Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health 100: 1506–1513.

26. Hippisley-CoxJ, CouplandC (2011) Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ 343: d4656.

27. EngaKF, BraekkanSK, Hansen-KroneIJ, le CessieS, RosendaalFR, et al. (2012) Cigarette smoking and the risk of venous thromboembolism: The Tromso Study. J Thromb Haemost 10: 2068–2074.

28. WattanakitK, LutseyPL, BellEJ, GornikH, CushmanM, et al. (2012) Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb Haemost 108: 508–515.

29. SweetlandS, ParkinL, BalkwillA, GreenJ, ReevesG, et al. (2013) Smoking, surgery, and venous thromboembolism risk in women: United Kingdom cohort study. Circulation 127: 1276–1282.

30. DreyerNA, PizzoSV (1980) Blood coagulation and idiopathic thromboembolism among fertile women. Contraception 22: 123–135.

31. LuY, HuiR, ZhaoY (2001) [Insertion/deletion polymorphsim of the angiotensin I converting enzyme gene and pulmonary thromboembolism in Chinese population]. Zhonghua Jie He He Hu Xi Za Zhi 24: 265–268.

32. RayJG, LangmanLJ, VermeulenMJ, EvrovskiJ, YeoEL, et al. (2001) Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women. Curr Control Trials Cardiovasc Med 2: 141–149.

33. TosettoA, FrezzatoM, RodeghieroF (2003) Prevalence and risk factors of non-fatal venous thromboembolism in the active population of the VITA Project. J Thromb Haemost 1: 1724–1729.

34. WorralurtC, TaneepanichskulS (2005) Risk factors of venous thromboembolism (VTE) in Thai reproductive aged female: King Chulalongkorn Memorial Hospital experience. J Med Assoc Thai 88: 1502–1505.

35. HirohashiT, YoshinagaK, SakuraiT, KanaiM, ShimizuK, et al. (2006) [Study of the echocardiographic diagnosis of acute pulmonary thromboembolism and risk factors for venous thromboembolism]. J Cardiol 47: 63–71.

36. SugimuraK, SakumaM, ShiratoK (2006) Potential risk factors and incidence of pulmonary thromboembolism in Japan: results from an overview of mailed questionnaires and matched case-control study. Circ J 70: 542–547.

37. PompER, RosendaalFR, DoggenCJ (2008) Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol 83: 97–102.

38. PrandoniP, BiloraF, MarchioriA, BernardiE, PetrobelliF, et al. (2003) An association between atherosclerosis and venous thrombosis. N Engl J Med 348: 1435–1441.

39. JangMJ, ChoiWI, BangSM, LeeT, KimYK, et al. (2009) Metabolic syndrome is associated with venous thromboembolism in the Korean population. Arterioscler Thromb Vasc Biol 29: 311–315.

40. YamadaN, OtaS, LiuY, CraneMM, ChangCM, et al. (2010) Risk factors for nonfatal pulmonary embolism in a Japanese population: a hospital-based case-control study. Angiology 61: 269–274.

41. BhoopatL, RojnuckarinP, HiransuthikulN, IntragumtornchaiT (2010) Low vegetable intake is strongly associated with venous thromboembolism in Thai population. Blood Coagul Fibrinolysis 21: 758–763.

42. Quist-PaulsenP, NaessIA, CannegieterSC, RomundstadPR, ChristiansenSC, et al. (2010) Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Haematologica 95: 119–125.

43. ZhuJ, ZhengWJ, KongFC, ZhangWJ, WangHY, et al. (2010) CYP1A1, smoking and venous thromboembolism. Thromb Haemost 104: 702–708.

44. CayN, IpekA, GumusM, BirkanZ, OzmenE (2012) Platelet activity indices in patients with deep vein thrombosis. Clin Appl Thromb Hemost 18: 206–210.

45. Di MinnoMN, TufanoA, GuidaA, Di CapuaM, De GregorioAM, et al. (2011) Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. Thromb Res 127: 193–197.

46. AbudurehemanK, MahemutiA, XiaYN, HuXM (2012) [Association between gene polymorphisms of methylenetetrahydrofolate reductase and plasma homocysteine in Uygur patients with venous thromboembolism]. Zhonghua Xin Xue Guan Bing Za Zhi 40: 1030–1036.

47. CilH, YavuzC, IslamogluY, TekbasEO, DemirtasS, et al. (2012) Platelet count and mean platelet volume in patients with in-hospital deep venous thrombosis. Clin Appl Thromb Hemost 18: 650–653.

48. BlondonM, WigginsKL, McKnightB, PsatyBM, RiceKM, et al. (2013) The association of smoking with venous thrombosis in women. A population-based, case-control study. Thromb Haemost 109.

49. ParkinL, SweetlandS, BalkwillA, GreenJ, ReevesG, et al. (2012) Body mass index, surgery, and risk of venous thromboembolism in middle-aged women: a cohort study. Circulation 125: 1897–1904.

50. SchmidtM, JohannesdottirSA, LemeshowS, LashTL, UlrichsenSP, et al. (2013) Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study. BMJ Open 3: e002698.

51. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 346: 1575–1582.

52. SultanAA, TataLJ, WestJ, FiaschiL, FlemingKM, et al. (2013) Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom. Blood 121: 3953–3961.

53. KawasakiT, KambayashiJ, AriyoshiH, SakonM, SuehisaE, et al. (1997) Hypercholesterolemia as a risk factor for deep-vein thrombosis. Thromb Res 88: 67–73.

54. HorstedF, WestJ, GraingeMJ (2012) Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med 9: e1001275 doi:10.1371/journal.pmed.1001275

55. JanuelJM, ChenG, RuffieuxC, QuanH, DouketisJD, et al. (2012) Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review. JAMA 307: 294–303.

56. ScarabinPY, OgerE, Plu-BureauG (2003) Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 362: 428–432.

57. SegalJB, BrotmanDJ, NecocheaAJ, EmadiA, SamalL, et al. (2009) Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. JAMA 301: 2472–2485.

58. SeverinsenMT, OvervadK, JohnsenSP, DethlefsenC, MadsenPH, et al. (2010) Genetic susceptibility, smoking, obesity and risk of venous thromboembolism. Br J Haematol 149: 273–279.

59. LeeKW, LipGY (2003) Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 163: 2368–2392.

60. MillerGJ, BauerKA, CooperJA, RosenbergRD (1998) Activation of the coagulant pathway in cigarette smokers. Thromb Haemost 79: 549–553.

61. YarnellJW, SweetnamPM, RumleyA, LoweGD (2000) Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly Study. Arterioscler Thromb Vasc Biol 20: 271–279.

62. OgerE, LacutK, Van DredenP, BressolletteL, AbgrallJF, et al. (2003) High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly. Haematologica 88: 465–469.

63. FeherMD, RamplingMW, BrownJ, RobinsonR, RichmondW, et al. (1990) Acute changes in atherogenic and thrombogenic factors with cessation of smoking. J R Soc Med 83: 146–148.

64. BakhruA, ErlingerTP (2005) Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med 2: e160 doi:10.1371/journal.pmed.0020160

65. YarnellJW, SweetnamPM, RumleyA, LoweGD (2001) Lifestyle factors and coagulation activation markers: the Caerphilly Study. Blood Coagul Fibrinolysis 12: 721–728.

66. YukizawaY, InabaY, WatanabeS, YajimaS, KobayashiN, et al. (2012) Association between venous thromboembolism and plasma levels of both soluble fibrin and plasminogen-activator inhibitor 1 in 170 patients undergoing total hip arthroplasty. Acta Orthop 83: 14–21.

67. GaryT, HafnerF, FroehlichH, StojakovicT, ScharnaglH, et al. (2010) High factor VIII activity, high plasminogen activator inhibitor 1 antigen levels and low factor XII activity contribute to a thrombophilic tendency in elderly venous thromboembolism patients. Acta Haematol 124: 214–217.

68. WilliC, BodenmannP, GhaliWA, FarisPD, CornuzJ (2007) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298: 2654–2664.

69. YehJM, HurC, SchragD, KuntzKM, EzzatiM, et al. (2013) Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation model. PLoS Med 10: e1001451 doi:10.1371/journal.pmed.1001451

70. KhawKT, FriesenMD, RiboliE, LubenR, WarehamN (2012) Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study. PLoS Med 9: e1001255.

71. LutseyPL, VirnigBA, DurhamSB, SteffenLM, HirschAT, et al. (2010) Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health 100: 1506–1513.

72. GrumelliS, CorryDB, SongLZ, SongL, GreenL, et al. (2004) An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 1: e8.

73. SchneiderC, BothnerU, JickSS, MeierCR (2010) Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol 25: 253–260.

74. GordonT, KannelWB, DawberTR, McGeeD (1975) Changes associated with quitting cigarette smoking: the Framingham Study. Am Heart J 90: 322–328.

75. Smoking wastes a good Parisienne. JAMA 262: 1185–1186.

76. AlbanesD, JonesDY, MicozziMS, MattsonME (1987) Associations between smoking and body weight in the US population: analysis of NHANES II. Am J Public Health 77: 439–444.

77. ShimokataH, MullerDC, AndresR (1989) Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA 261: 1169–1173.

78. CushmanM, KullerLH, PrenticeR, RodaboughRJ, PsatyBM, et al. (2004) Estrogen plus progestin and risk of venous thrombosis. JAMA 292: 1573–1580.